| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/21/2007 | WO2007021343A3 Pharmacokinetic-based culture system with biological barriers |
| 06/21/2007 | WO2007002664A3 Propagation of undifferentiated embryonic stem cells in hyaluronic acid hydrogel |
| 06/21/2007 | WO2007002167A3 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells |
| 06/21/2007 | WO2006136351A3 Methods for altering the reactivity of plant cell walls |
| 06/21/2007 | WO2006121445A3 Therapy of kidney diseases and multiorgan failure with mesenchymal stem cells and mesenchymal stem cell conditioned media |
| 06/21/2007 | WO2006120230A3 Host cell specific binding molecules capable of neutralizing viruses and uses thereof |
| 06/21/2007 | WO2006101782A3 A cysteine-containing peptide tag for site-specific conjugation of proteins |
| 06/21/2007 | WO2006084111A3 Optimization of heterologous polypeptide expression |
| 06/21/2007 | WO2006081350A8 Methods and compositions for the diagnosis and treatment of schizophrenia |
| 06/21/2007 | WO2006071435A3 Methods for correcting mitotic spindle defects and optimizing preimplantation embryonic developmental rates associated with somatic cell nuclear transfer in animals |
| 06/21/2007 | WO2006065724A3 Casein kinase 2 antisense therapy |
| 06/21/2007 | WO2006055915A3 Methods for producing mammalian cells |
| 06/21/2007 | WO2006047242A8 Duffy antigen receptor for chemokines and use thereof |
| 06/21/2007 | WO2006031779A9 Promoter molecules for use in plants |
| 06/21/2007 | WO2005005615A3 Anti-mullerian inhibiting substance type ii receptor (misiir) immunoconjugates to detect and treat cancer |
| 06/21/2007 | WO2003064628A3 Novel proteins and nucleic acids encoding same |
| 06/21/2007 | US20070143879 F-box protein targeted plant oil production |
| 06/21/2007 | US20070143877 Plant virus vector |
| 06/21/2007 | US20070143874 Rice hybrid XL730 |
| 06/21/2007 | US20070143871 Non-human transgenic animal models for hepatocellular carcinoma |
| 06/21/2007 | US20070143868 Sperm Cell Processing and Preservation Systems |
| 06/21/2007 | US20070143866 Human photoaged skin model |
| 06/21/2007 | US20070142724 Medium and method for measuring the efficacy of a tumour therapy |
| 06/21/2007 | US20070142312 Antigen delivery system |
| 06/21/2007 | US20070142295 Thrombopoietic compounds |
| 06/21/2007 | US20070142294 Identification and cloning of novel human gene, RET16, involved in the intracellular signaling cascade |
| 06/21/2007 | US20070142280 Factor VII or VIIa-like molecules |
| 06/21/2007 | US20070141706 Adenovirus packaging cell lines |
| 06/21/2007 | US20070141705 Method for producing viral vectors |
| 06/21/2007 | US20070141704 Cell fusions and methods of making and using the same |
| 06/21/2007 | US20070141703 Methods for producing blood products from pluripotent cells in cell culture |
| 06/21/2007 | US20070141702 by manipulation of O2 tension, including manipulation of Ca2+ under high O2 tension and contacting oocytes with serine threonine kinase inhibitors under low O2 tension, isolating inner cell masses (ICMs) from the activated oocytes, and culturing the cells of the isolated ICMs under high O2 tension |
| 06/21/2007 | US20070141701 Hepatitis c virus ns2/3 assay |
| 06/21/2007 | US20070141700 In vitro expansion of postpartum-derived cells in roller bottles |
| 06/21/2007 | US20070141699 Methods of using the signal to transmit and maintain influenza viral and foreign nucleic acid in virus and cells; hemagglutinin (HA) and neuraminidase (NA). |
| 06/21/2007 | US20070141697 forming patterning substrate by forming on base material a light shielding portion and a cell adhesive layer having adhesion to cell and containing cell adhesive material which is decomposed or denatured by action of photocatalyst upon energy irradiation so as to cover light shielding portion |
| 06/21/2007 | US20070141669 Pregnancy-associated plasma protein-A2 (PAPP-A2) |
| 06/21/2007 | US20070141646 Preparation of red blood cells with a modified level of blood group antigen expression and their use in the quality control of blood typing reagents |
| 06/21/2007 | US20070141643 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 06/21/2007 | US20070141641 Compositions & methods for reformulating biological membranes for arrays |
| 06/21/2007 | US20070141592 Thermostable reverse transcriptases and uses thereof |
| 06/21/2007 | US20070141590 Modulators of tissue regeneration |
| 06/21/2007 | US20070141579 MUM-1 protein expressed by multiple myeloma-related gene |
| 06/21/2007 | US20070141568 Method for determining the presence of one or more ligands in a sample |
| 06/21/2007 | US20070141554 Stable cell lines expressing hERG |
| 06/21/2007 | US20070141552 Automatable artificial immune system (AIS) |
| 06/21/2007 | US20070141164 Methods and gel compositions for encapsulating living cells and organic molecules |
| 06/21/2007 | US20070141105 Engineered Biological Matrices |
| 06/21/2007 | US20070141087 Compounds and methods for diagnosis of tuberculosis |
| 06/21/2007 | US20070141085 Recombinant protective protein from Streptococcus pneumoniae |
| 06/21/2007 | US20070141065 capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, edema, inflammation |
| 06/21/2007 | US20070141064 Fully human hybridoma fusion partner cell lines |
| 06/21/2007 | US20070141054 Anti-A33 antibody that specifically binds to an A33 antigen; a preventive or therapeutic agent for diseases due to A33-expressing cells, and in particular, a molecule that is also useful as a malignant tumor remedy for patients with A33 polymorphism, are provided |
| 06/21/2007 | US20070141047 Feline immunoglobulin e proteins and compositions thereof |
| 06/21/2007 | US20070141038 Gene repair involving the induction of double-stranded DNA cleavage at a chromosomal target site |
| 06/21/2007 | US20070141037 improved tissue graft construct comprising submucosa of a warm-blooded vertebrate and a preselected group of eukaryotic cells ; used to enhance the repair of damaged or diseased tissues in vivo |
| 06/21/2007 | US20070141035 Pluripotent olfactory stem cells |
| 06/21/2007 | US20070141034 Methods for isolating t cells and uses thereof |
| 06/21/2007 | US20070141033 Purging of cells using viruses |
| 06/21/2007 | US20070141026 Immunotherapy in cancer treatment |
| 06/21/2007 | CA2633601A1 Methods for obtaining immortalized antibody secreting cells |
| 06/21/2007 | CA2633201A1 Skin care compositions and treatments |
| 06/21/2007 | CA2632762A1 Barley row type gene and use thereof |
| 06/21/2007 | CA2632142A1 Nuclear reprogramming factor |
| 06/21/2007 | CA2631877A1 Method for detecting the presence or absence of a target cell in a sample |
| 06/21/2007 | CA2630811A1 Improved production of glycoproteins using manganese |
| 06/20/2007 | EP1798288A2 Human Toll-like receptor proteins, related reagents and methods |
| 06/20/2007 | EP1798287A2 Mammalian cell membrane proteins and related reagents |
| 06/20/2007 | EP1798286A2 Mammalian cell membrane proteins and related reagents |
| 06/20/2007 | EP1798243A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumors |
| 06/20/2007 | EP1798242A2 New anti-GF-IR antibodies and their applications |
| 06/20/2007 | EP1798239A2 G-protein coupled receptors and uses therefor |
| 06/20/2007 | EP1797754A1 Transcription factor stress-related proteins and methods of use in plants |
| 06/20/2007 | EP1797427A2 Methods for identifying new drug leads and new therapeutic uses for known drugs |
| 06/20/2007 | EP1797186A1 Expression system, components thereof and methods of use |
| 06/20/2007 | EP1797182A2 Methods and compositions for improving recombinant protein production |
| 06/20/2007 | EP1797178A2 Citrobacter freundii phytase and homologues |
| 06/20/2007 | EP1797172A2 Culturing human embryonic stem cells |
| 06/20/2007 | EP1797171A1 Methods for the generation of hepatocyte-like cells from human blastocyst-derived stem (hbs) |
| 06/20/2007 | EP1796713A1 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response |
| 06/20/2007 | EP1796686A2 Emmprin antagonists and uses thereof |
| 06/20/2007 | EP1796592A1 Method for in situ repair of injured, damaged, diseased or aged articular cartilage using neo-cartilage constructs and a method for preparation thereof |
| 06/20/2007 | EP1796474A2 Methods for the isolation and expansion of cord blood derived t regulatory cells |
| 06/20/2007 | EP1567653B1 Recombinant poxvirus comprising at least two cowpox ati promoters |
| 06/20/2007 | EP1534256A4 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/20/2007 | EP1532239A4 Methods and compositions for targeting secretory lysosomes |
| 06/20/2007 | EP1485410B1 Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases |
| 06/20/2007 | EP1438559B1 Flow control metering system and method for controlling filtration of liquid-based specimens |
| 06/20/2007 | EP1409688B1 Nucleic acid sequences encoding enantioselective amidases |
| 06/20/2007 | EP1358353B1 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 06/20/2007 | EP1272204B1 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
| 06/20/2007 | EP1200615B8 Nucleic acid molecules derived from plants which code for enzymes which are involved in the synthesis of starch |
| 06/20/2007 | EP1179010B1 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 06/20/2007 | EP1124946B1 Glycosylated proteins having reduced allergenicity |
| 06/20/2007 | EP1105408B1 Congugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 06/20/2007 | EP1056838B1 Method for the development of an hiv vaccine |
| 06/20/2007 | EP0745121B1 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 06/20/2007 | CN1984999A Tolerance-induced targeted antibody production |
| 06/20/2007 | CN1984991A P1-35 expression units |
| 06/20/2007 | CN1984925A Genes and polypeptides relating to prostate cancers |